2022 Q4 Form 20-F Financial Statement
#000117891323001008 Filed on March 15, 2023
Income Statement
| Concept | 2022 Q4 | 2022 | 2021 Q4 |
|---|---|---|---|
| Revenue | $209.7M | $640.3M | $158.0M |
| YoY Change | 32.72% | 33.81% | 33.54% |
| Cost Of Revenue | $9.390M | $30.40M | $7.318M |
| YoY Change | 28.31% | 20.67% | 12.58% |
| Gross Profit | $200.3M | $609.9M | $150.7M |
| YoY Change | 32.94% | 34.54% | 34.88% |
| Gross Profit Margin | 95.52% | 95.25% | 95.37% |
| Selling, General & Admin | $24.02M | $79.83M | $23.68M |
| YoY Change | 1.43% | 7.67% | 49.85% |
| % of Gross Profit | 11.99% | 13.09% | 15.72% |
| Research & Development | $9.289M | $34.42M | $9.245M |
| YoY Change | 0.48% | -2.61% | 8.76% |
| % of Gross Profit | 4.64% | 5.64% | 6.14% |
| Depreciation & Amortization | $3.741M | $13.84M | $3.598M |
| YoY Change | 3.97% | 39.82% | 34.76% |
| % of Gross Profit | 1.87% | 2.27% | 2.39% |
| Operating Expenses | $37.05M | $531.1M | $36.52M |
| YoY Change | 1.44% | 344.85% | 35.26% |
| Operating Profit | $163.2M | $109.2M | $114.1M |
| YoY Change | 43.02% | -67.31% | 34.75% |
| Interest Expense | $1.976M | $4.502M | -$465.0K |
| YoY Change | -524.95% | -501.96% | -66.79% |
| % of Operating Profit | 1.21% | 4.12% | -0.41% |
| Other Income/Expense, Net | $4.502M | ||
| YoY Change | 735.25% | ||
| Pretax Income | $43.16M | $113.7M | $20.33M |
| YoY Change | 112.32% | 150.83% | 139.18% |
| Income Tax | $4.487M | $14.44M | $2.635M |
| % Of Pretax Income | 10.4% | 12.7% | 12.96% |
| Net Earnings | $38.68M | $99.23M | $17.70M |
| YoY Change | 118.58% | 156.36% | 96.61% |
| Net Earnings / Revenue | 18.45% | 15.5% | 11.2% |
| Basic Earnings Per Share | $2.21 | ||
| Diluted Earnings Per Share | $0.79 | $2.06 | $434.6K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 46.17M shares | 44.87M shares | |
| Diluted Shares Outstanding | 48.07M shares |
Balance Sheet
| Concept | 2022 Q4 | 2022 | 2021 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $429.6M | $429.6M | $321.6M |
| YoY Change | 33.57% | 33.57% | 432.53% |
| Cash & Equivalents | $176.2M | $176.2M | $104.4M |
| Short-Term Investments | $253.4M | $253.4M | $217.2M |
| Other Short-Term Assets | $13.34M | $13.34M | $9.164M |
| YoY Change | 45.61% | 45.61% | 58.0% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | $160.5M | $160.5M | $115.4M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $603.5M | $603.5M | $446.2M |
| YoY Change | 35.25% | 35.25% | 202.69% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $3.611M | $13.74M | $15.79M |
| YoY Change | -77.13% | -12.97% | -41.52% |
| Goodwill | $195.5M | $189.3M | |
| YoY Change | 3.31% | 24.27% | |
| Intangibles | $51.66M | $56.70M | |
| YoY Change | -8.88% | ||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $49.00K | $5.828M | $5.307M |
| YoY Change | -99.08% | 9.82% | -30.17% |
| Total Long-Term Assets | $266.8M | $266.8M | $267.1M |
| YoY Change | -0.11% | -0.11% | 26.39% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $603.5M | $603.5M | $446.2M |
| Total Long-Term Assets | $266.8M | $266.8M | $267.1M |
| Total Assets | $870.2M | $870.2M | $713.2M |
| YoY Change | 22.01% | 22.01% | 98.84% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $155.9M | $155.9M | $107.7M |
| YoY Change | 44.67% | 44.67% | 48.59% |
| Accrued Expenses | $37.87M | $41.77M | $43.95M |
| YoY Change | -13.83% | -3.32% | 71.0% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $0.00 | ||
| YoY Change | -100.0% | ||
| Total Short-Term Liabilities | $234.6M | $234.6M | $193.7M |
| YoY Change | 21.11% | 21.11% | 61.29% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $11.78M | $52.48M | $52.57M |
| YoY Change | -77.58% | -0.17% | -3.37% |
| Total Long-Term Liabilities | $11.78M | $52.48M | $52.57M |
| YoY Change | -77.58% | -0.17% | -3.37% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $234.6M | $234.6M | $193.7M |
| Total Long-Term Liabilities | $11.78M | $52.48M | $52.57M |
| Total Liabilities | $287.1M | $287.1M | $246.3M |
| YoY Change | 16.57% | 16.57% | 41.05% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | $70.79M | -$28.44M | |
| YoY Change | -348.9% | ||
| Common Stock | $513.9M | $496.5M | |
| YoY Change | 3.5% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $1.002M | $1.002M | |
| YoY Change | 0.0% | ||
| Treasury Stock Shares | 115.3K shares | 115.3K shares | |
| Shareholders Equity | $583.1M | $583.1M | $467.0M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $870.2M | $870.2M | $713.2M |
| YoY Change | 22.01% | 22.01% | 98.84% |
Cashflow Statement
| Concept | 2022 Q4 | 2022 | 2021 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $38.68M | $99.23M | $17.70M |
| YoY Change | 118.58% | 156.36% | 96.61% |
| Depreciation, Depletion And Amortization | $3.741M | $13.84M | $3.598M |
| YoY Change | 3.97% | 39.82% | 34.76% |
| Cash From Operating Activities | $38.17M | $122.1M | $28.84M |
| YoY Change | 32.37% | 71.74% | 123.19% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $267.0K | $1.058M | -$132.0K |
| YoY Change | -302.27% | -268.74% | 88.57% |
| Acquisitions | $9.570M | ||
| YoY Change | -75.1% | ||
| Other Investing Activities | -$34.40M | -$45.77M | -$192.1M |
| YoY Change | -82.09% | -81.15% | 4122.09% |
| Cash From Investing Activities | -$34.67M | -$46.82M | -$192.2M |
| YoY Change | -81.97% | -80.77% | 4051.99% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $171.5M | ||
| YoY Change | 7694.86% | ||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 1.392M | -$3.258M | 171.5M |
| YoY Change | -99.19% | -101.42% | -1484.08% |
| NET CHANGE | |||
| Cash From Operating Activities | 38.17M | $122.1M | 28.84M |
| Cash From Investing Activities | -34.67M | -$46.82M | -192.2M |
| Cash From Financing Activities | 1.392M | -$3.258M | 171.5M |
| Net Change In Cash | 4.895M | $71.99M | 8.086M |
| YoY Change | -39.46% | 26.98% | -297.22% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $38.17M | $122.1M | $28.84M |
| Capital Expenditures | $267.0K | $1.058M | -$132.0K |
| Free Cash Flow | $37.90M | $121.1M | $28.97M |
| YoY Change | 30.84% | 68.77% | 123.0% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
pure | |
| CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
| CY2022 | dei |
Auditor Location
AuditorLocation
|
Tel-Aviv, Israel | |
| CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
| CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
| CY2021Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
115339 | shares |
| CY2022Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
115339 | shares |
| CY2022 | us-gaap |
Revenues
Revenues
|
640256000 | usd |
| CY2021 | us-gaap |
Revenues
Revenues
|
478498000 | usd |
| CY2020 | us-gaap |
Revenues
Revenues
|
328063000 | usd |
| CY2022 | peri |
Cost Of Revenue Expense
CostOfRevenueExpense
|
30404000 | usd |
| CY2021 | peri |
Cost Of Revenue Expense
CostOfRevenueExpense
|
25197000 | usd |
| CY2020 | peri |
Cost Of Revenue Expense
CostOfRevenueExpense
|
22477000 | usd |
| CY2022 | peri |
Traffic Acquisition Costs And Media Buy
TrafficAcquisitionCostsAndMediaBuy
|
372601000 | usd |
| CY2021 | peri |
Traffic Acquisition Costs And Media Buy
TrafficAcquisitionCostsAndMediaBuy
|
288018000 | usd |
| CY2020 | peri |
Traffic Acquisition Costs And Media Buy
TrafficAcquisitionCostsAndMediaBuy
|
197626000 | usd |
| CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
34424000 | usd |
| CY2021 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
35348000 | usd |
| CY2020 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
30880000 | usd |
| CY2022 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
56014000 | usd |
| CY2021 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
53209000 | usd |
| CY2020 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
39085000 | usd |
| CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
23813000 | usd |
| CY2021 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
20933000 | usd |
| CY2020 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
15819000 | usd |
| CY2022 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
13838000 | usd |
| CY2021 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
9897000 | usd |
| CY2020 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
9923000 | usd |
| CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
531094000 | usd |
| CY2021 | us-gaap |
Operating Expenses
OperatingExpenses
|
432602000 | usd |
| CY2020 | us-gaap |
Operating Expenses
OperatingExpenses
|
315810000 | usd |
| CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
109162000 | usd |
| CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
45896000 | usd |
| CY2020 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
12253000 | usd |
| CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
4502000 | usd |
| CY2021 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-581000 | usd |
| CY2020 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-2638000 | usd |
| CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
113664000 | usd |
| CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
45315000 | usd |
| CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
9615000 | usd |
| CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
14439000 | usd |
| CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
6609000 | usd |
| CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-610000 | usd |
| CY2022 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
99225000 | usd |
| CY2021 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
38706000 | usd |
| CY2020 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
10225000 | usd |
| CY2022 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
2.21 | |
| CY2021 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
1.13 | |
| CY2020 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.38 | |
| CY2022 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
2.06 | |
| CY2021 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
1.02 | |
| CY2020 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.36 | |
| CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
44871149 | shares |
| CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
34397134 | shares |
| CY2020 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
26687145 | shares |
| CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
48071638 | shares |
| CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
37829725 | shares |
| CY2020 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
28797747 | shares |
| CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
165182000 | usd |
| CY2022 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-454000 | usd |
| CY2022 | peri |
Change In Fair Value Of Payment Obligation Related To Acquisition
ChangeInFairValueOfPaymentObligationRelatedToAcquisition
|
-6904000 | usd |
| CY2022 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
0 | usd |
| CY2021 | peri |
Change In Fair Value Of Payment Obligation Related To Acquisition
ChangeInFairValueOfPaymentObligationRelatedToAcquisition
|
350000 | usd |
| CY2020 | peri |
Change In Fair Value Of Payment Obligation Related To Acquisition
ChangeInFairValueOfPaymentObligationRelatedToAcquisition
|
4646000 | usd |
| CY2021 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
230489000 | usd |
| CY2020 | us-gaap |
Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
|
0 | usd |
| CY2022 | us-gaap |
Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
|
0 | usd |
| CY2021 | us-gaap |
Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
|
8333000 | usd |
| CY2020 | peri |
Creation Of Right Of Use Assets
CreationOfRightOfUseAssets
|
1671000 | usd |
| CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <div style="margin-top:14px;margin-left:60pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><i><span><span>Use of estimates</span></span></i></span></span></span></span></span></div> <div style="margin-top:14px;margin-left:60pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The preparation of the consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company's management evaluates its estimates, including those related to sales allowances and allowance for credit losses, fair value of intangible assets and goodwill, useful lives of intangible assets, fair value of share-based awards, realizability of deferred tax assets, tax uncertainties, and contingent liabilities, among others. </span></span></span><span>Such estimates are based on </span><span>historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of the Company’s assets and liabilities.</span></span></span></div> </div> | |
| CY2022Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
1295000 | usd |
| CY2021Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
1089000 | usd |
| CY2022Q4 | peri |
Remaining Performance Obligations
RemainingPerformanceObligations
|
2377000 | usd |
| CY2021 | us-gaap |
Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
|
3056000 | usd |
| CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
456696 | shares |
| CY2021 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1035307 | shares |
| CY2020 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3178024 | shares |
| CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div> <div style="margin-top:14px;margin-left:60pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><i><span><span>Concentrations of credit risk</span></span></i></span></span></span></span></span></div> <div style="margin-top:14px;margin-left:60pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:normal;color:black">Financial instruments, which potentially subject the Company to a concentration of credit risk, consist primarily of cash and cash equivalents, bank deposits, restricted cash and accounts receivable.</span></span></span></span></span></div> <div style="margin-top:14px;margin-left:60pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:normal;color:black">The majority of the Company’s cash and cash equivalents, bank deposits and restricted cash are invested in USD instruments with major banks in the U.S. and Israel. Generally, these deposits may be redeemed upon demand and, therefore, bear minimal risk. </span></span></span></span></span></div> <div style="margin-top:14px;margin-left:60pt;margin-bottom:14px;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:normal;color:black">The Company’s major customers are financially sound, and the Company believes low credit risk is associated with these customers. To date, the Company has not experienced any material credit losses.</span></span></span></span></span> <p style="margin:0pt"> </p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:normal;color:black">The allowance against gross trade receivables reflects the current expected credit loss inherent in the receivables portfolio determined based on the Company’s methodology. The Company’s methodology is based on historical collection experience, customer creditworthiness, current and future economic condition, and market condition. Additionally, specific allowance amounts are established to record the appropriate provision for customers that have a higher probability of default. Trade receivables are written off after all reasonable means to collect the full amount have been exhausted.</span></span></span></span></span> </div> </div> | |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2022Q4 | peri |
Obligation Related To Acquisitions
ObligationRelatedToAcquisitions
|
331000 | usd |
| CY2021Q4 | peri |
Obligation Related To Acquisitions
ObligationRelatedToAcquisitions
|
8725000 | usd |
| CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
777000 | usd |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
20.13 | |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
18.55 | |
| CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.14 | |
| CY2022 | peri |
Other Non Operating Income Expense Other
OtherNonOperatingIncomeExpenseOther
|
0 | usd |
| CY2021 | peri |
Other Non Operating Income Expense Other
OtherNonOperatingIncomeExpenseOther
|
0 | usd |
| CY2020 | peri |
Other Non Operating Income Expense Other
OtherNonOperatingIncomeExpenseOther
|
45000 | usd |
